Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Washington, D.C., set a world record of most couples kissing underneath the mistletoe. Exactly 1,435 couples turned up to smooch for five seconds under the festive greenery on Saturday. Washington, ...

Benin's coup leaders appear on state TV on Dec. 7, 2025, to announce the suspension of the country's constitution. Reuters/YouTube In a scene that has become familiar across parts of Africa of late, a ...

STATEWIDE — GOV. KATHY HOCHUL has launched POWER UP, a $300 million initiative to make New York’s industrial sites both shovel-ready and power-ready for next-generation industries, including ...

The shale play that provides the most US energy production is struggling to find ways to power itself. Operators and service companies in the Permian basin, the most prolific US region at about 6 ...

WASHINGTON — As part of next steps for the Janus Program, the Department of the Army has selected nine installations for consideration in which to site microreactor power plants, and the Defense ...

IOWA CITY, Iowa (KCRG) - The Iowa City Housing Authority announced a new landlord incentive program Thursday - looking to help 19 households find a place to stay this winter. Those families receive ...

These days, the Justice Department is so busy pursuing revenge against President Donald Trump’s enemies it’s a wonder they have time to do anything else. In fact, nearly half of all FBI agents in the ...

The company, which is organized as a real-estate investment trust, plans to make up a three-week delay in signing a final contract with its first tenant, but investors remained worried Fermi Inc.'s ...

This is read by an automated voice. Please report any issues or inconsistencies here. Southern California Edison cut power to more customers this year than ever before, nearly quadrupling blackouts to ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...